A blood test for early cancer detection
Screen Today
for More Tomorrows
A REVOLUTION IN EARLY CANCER DETECTION IS HERE
Cancer Check is a breakthrough Multi-Cancer Early Detection test (MCED). We detect solid tumor cancers as early as Stage 0 (1).
Cancer Check issues a board-certified pathology report with every test result. This means every screen is reviewed by a qualified medical doctor, adding an extra layer of trust and reliability to our results. This professional oversight ensures that you receive expert interpretation of the test results.
Cancer Check is the ONLY MCED blood test that provides a board-certified pathology report.
THE SIGNIFICANCE OF CIRCULATING TUMOR CELLS (CTCs)
If you're looking for a powerful early detection cancer screen, Cancer Check, our Circulating Tumor Cell based test, offers a minimally-invasive, highly specific, and clinically meaningful way to screen for real, active cancer, not just genetic noise. It's a chance to act before cancer becomes life-threatening.
Direct Evidence of Cancer Activity
CTCs are malignant tumor cells that enter the bloodstream after breaking away from a solid tumor.
- Their presence indicates active cancer, not just risk or mutations.
Provides Complete Cell Data
More complete, reliable information. No guesswork from partial cell scraps.
- Unlike other cancer tests that look for broken DNA then extrapolate a result, CTCs are whole, intact cells that are examined by pathologists.
Works Across All Solid Tumors
Cancer Check can potentially detect any solid tumor type because all tumors shed CTCs.
- It's a universal cancer screening tool, not limited to specific cancers like breast or colon. Ideal for general early detection.
Verified by Pathologists
CTCs are stained and analyzed under a microscope using gold-standard methods.
- A board-certified pathologist reads the slides prepared using proven histology and immunohistochemistry methods, increasing results confidence. A pathology report is issued with every screening result.
CTCs Drive Metastasis
CTCs are the cells that cause cancer to spread to other parts of the body which can lead to metastatic cancer. This is the leading cause of cancer-related deaths.
- Early detection of CTCs means detecting cancer before it spreads, potentially stopping it at a treatable stage.
Results You Can Trust
Cancer Check detects solid tumors through a simple blood draw by identifying Circulating Tumor Cells (CTCs) within your blood.
Whole-body biopsy screening
Established and proven cancer staining protocols
Board-certified pathology report issued for every test
Our test captures entire tumor cells.
This allows us to employ gold-standard pathology methods to provide whole-body screens for cancer.
Unlike other tests, we focus on proven, reliable diagnostic methods. We avoid using less established techniques such as signaling, circulating tumor DNA (ctDNA) analysis, or artificial intelligence for our screening. These methods lack the consistent accuracy required for our standards.
WHY TEST
Cancer has a 99% survival rate when detected at Stage 0.
Early cancer screening plays a crucial role in saving lives by detecting cancer at its most treatable stages.
By intervening early, people can undergo less aggressive treatments, reduce the likelihood of cancer spreading, and ultimately improve their long-term outcomes and quality of life.
These symptoms don’t always indicate cancer but put your mind at ease and screen for all solid tumor cancers at once.
LATEST NEWS
We are now available in Pennsylvania, Maryland, and Rhode Island.
With this expansion, residents in these three states can now access Cancer Check Labs' innovative, comprehensive blood test, capable of detecting tumor-based cancers as early as Stage 0—often before any symptoms arise. This cutting-edge test offers unparalleled accuracy, giving individuals and healthcare providers a critical tool in the fight against cancer.
Cancer Check Labs welcome Dr Raj Attariwala to our Scientific & Medical Advisory Board
Dr. Attariwala is a co-author of Oncorads – a global standardized MRI technique for cancer screening, and the emeritus founder and creator of the Prenuvo scan and report. His expertise in PET/CT and whole-body MRI redefined imaging of early cancer detection and preventative healthcare.
Featured in D Magazine
After a soft launch in Dallas last year, Cancer Check Labs is now testing blood samples for cancer in 44 states and overseas. The company’s test can detect the growth of up to 200 types of solid tumors in just a 40 ml sample of a patient’s blood.
Latest News
Looking for Partnership Opportunities?
Medical Doctors
Find out how to offer this breakthrough test to your patients.
Functional Health
Learn how to provide this innovative test at your practice.
Wellness/MedSpas
Discover how to sell this test at your Wellness Center or Med Spa.
Employers
Learn how to bring this powerful benefit to your team.
Pricing
.png){kind=icon}
Frequently Asked Questions
You will get an email notification from results@cancerchecklabs.com when they are ready. Results are encrypted for your privacy and protection. We recommend that you always review the results with your primary care physician.
If you ordered Cancer Check through your physician's office, please contact them to obtain your results.
Click the Purchase button above to purchase your test kit or call us at: 214-301-0351 and we will be happy to assist you.
Generally, the test is available to everyone. At the time of the test, however, we do require that you meet the following criteria:
1. You are 21 years of age or older
2. You weigh over 90lbs/41kg
3. In the last 90 days, you have not:
3.1. Been pregnant
3.2. Received cancer treatment
3.3. Donated bone marrow
3.4. Undergone surgery or experienced any traumatic injury
Cancer risk increases for everyone as they age regardless of family history. Only around 10% of cancer risk is inherited.
Cancer Check is a multi-cancer early detection test that screens for more than 200 types and sub-types of solid tumor cancers.